One68 Global Capital’s BioVie BIVI Stock Holding History

One68 Global Capital’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-171	Closed	-$138K	–	29
2023 Q1	$138K	Buy	+171	New	+$113K	0.2%	37

Other funds holding BIVI

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

One68 Global Capital's BIVI Position: Q2 2023 in Review

One68 Global Capital sold out of BioVie (BIVI) in Q2 2023, closing a stake of 171 shares — an estimated $138K sold.

One68 Global Capital first reported a position in BIVI in Q1 2023 and held it in 1 quarter. The position peaked at $138K in Q1 2023. 53 funds tracked by Wall St. Rank hold BIVI as of Q2 2023.

One68 Global Capital reported no remaining BioVie position as of Q2 2023 after selling out during the quarter.
One68 Global Capital sold 171 BioVie shares in Q2 2023, an estimated $138K.
One68 Global Capital first reported a position in BioVie in Q1 2023 and held it in 1 quarter.
One68 Global Capital's BioVie position peaked at $138K in Q1 2023.
53 funds tracked by Wall St. Rank held BioVie as of Q2 2023.

Based on One68 Global Capital's 13F filing for Q2 2023, filed 14 Aug 2023.